Want to see AU:XEN full AI Analyst Report?
AuMake Ltd. (XEN) Price & Analysis
XEN Stock Chart & Stats
- Day’s Range
- AUD 0.01 - AUD 0.01
- 52-Week Range
- N/A
- Previous Close
- AUD 0.01
- Volume
- N/A
- Average Volume (3M)
- 1.95M
- Market Cap
- AUD 9.39M
- Enterprise Value
- AUD 6.54M
- Total Cash (Recent Filing)
- AUD 3.16M
- Total Debt (Recent Filing)
- AUD 1.21M
- Price to Earnings (P/E)
- ―
- Beta
- -0.60
- Next Earnings
- Mar 03, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Prior-year Revenue Expansion
Strong revenue growth in FY2025 demonstrates that the company has previously been capable of expanding sales, indicating some underlying market demand or execution potential. However, the benefit is tempered by the subsequent FY2026 reversal, so this remains an unproven foundation rather than a stable trend.
Improved Cash Burn
The substantial improvement in cash burn during FY2026 provides some evidence that cash consumption can be reduced through operating or working-capital changes. This could extend funding runway and support stabilization efforts, although ongoing negative free cash flow means the improvement has not yet created self-sustaining cash generation.
Earlier Margin Improvement
The improvement in loss margins during FY2025 indicates the business had previously made progress toward better operating efficiency. That experience may provide a basis for recovery initiatives, but the renewed FY2026 deterioration shows the improvement was not yet durable or sufficient to establish stable unit economics.
Bears Say
Sharp Revenue Deterioration
A roughly 40% year-over-year revenue decline is a major setback to scale, market position, and operating leverage. Such contraction reduces the revenue base available to cover fixed costs and makes a near-term return to sustainable profitability more difficult, especially after the prior year's growth proved reversible.
Structurally Negative Profitability
Losses at the gross-profit level indicate that the company is not currently covering its direct costs through revenue, while persistent operating and net losses show broader profitability remains structurally negative. Without a durable improvement in pricing, costs, or sales productivity, scale benefits are unlikely to emerge.
Balance-sheet And Funding Strain
Leverage of roughly 4.8 times equity, driven partly by a sharp equity decline, materially reduces financial flexibility. Combined with shrinking assets and negative shareholder returns, the weakened capital base increases refinancing and solvency risk if losses continue and may constrain investment in recovery.
AuMake Ltd. News
XEN FAQ
What is AuMake Ltd.’s market cap?
When is AuMake Ltd.’s upcoming earnings report date?
How were AuMake Ltd.’s earnings last quarter?
Is AuMake Ltd. overvalued?
Does AuMake Ltd. pay dividends?
What is AuMake Ltd.’s EPS estimate?
How many shares outstanding does AuMake Ltd. have?
What happened to AuMake Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AuMake Ltd.?
What is the TipRanks Smart Score and how is it calculated?
AuMake Ltd. Stock Smart Score
Company Description
AuMake Ltd.
Xenitra Limited operates an e-commerce platform, facilitating the online sale of a broad spectrum of products throughout Australia, Hong Kong, Mainland China, and New Zealand. Its extensive inventory features a wide selection of beverages, both alcoholic and non-alcoholic, alongside a comprehensive range of food items. These food offerings encompass dairy products, fresh produce, seafood, honey, wine, and various meats such as beef, mutton, and lamb. The company also supplies health and beauty essentials, from vitamins, protein, and meal replacement supplements to herbal teas, skincare, haircare, and cosmetics. Further diversifying its portfolio, Xenitra offers fashion apparel, homewares, artisanal crafts, metalwork, and leather goods. It also addresses holistic health and wellbeing, providing an array of vitamins, nutritional and mineral supplements, non-prescription medications, and pharmaceutical products developed in Australian and New Zealand laboratories. Beyond retail, the company delivers critical business-to-business services, including international import and export solutions, warehousing facilities, and comprehensive freight and logistics support. Xenitra also extends its expertise to marketing, encompassing brand strategy formulation, the development of omnichannel marketing campaigns, live streaming capabilities, and both content management and creation. Incorporated in 2011 and headquartered in Sydney, Australia, the company transitioned from its previous name, AuMake Limited, to Xenitra Limited in March 2026.
- Sector
- Consumercyclical
- Industry
- Department Stores
- CEO
- Anthony Guarna
- Employees
- 0
- Website
- xenitra.com
- Address
- 270 Adelaide St, Brisbane, QLD, 4000, AU